查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2154067

關節慢性疼痛治療​​方案市場：全球市場預測，2026-2032年

Chronic Pain Therapy Solutions for Joints Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，慢性關節疼痛治療解決方案的市場規模將成長至 66.9 億美元，複合年成長率為 6.10%。

主要市場統計數據
基準年 2025 44.2億美元
預計年份：2026年 46.4億美元
預測年份 2032 66.9億美元
複合年成長率 (%) 6.10%

慢性關節疼痛治療方案概述

慢性關節疼痛是一種長期存在的健康問題，與骨關節炎、發炎性關節炎、先前創傷、老齡化相關性退化以及其他肌肉骨骼疾病有關。治療方案包括非藥物療法、藥物治療、注射治療、物理治療、輔助技術和手術介入。臨床決策越來越注重個體化治療、功能改善、安全性和協調的長期管理，而不是依賴單一療法。

護理正在轉向更加多方面和以功能為中心的管理方法。

治療方法正朝著多方面模式轉變，該模式結合了運動療法、臨床適宜的體重管理、健康教育、行為支持、藥物治療和介入措施。隨著人們越來越關注鴉片類藥物的合理使用、不利事件的減少、以患者為中心的決策以及早期康復，臨床實踐正在重組。數位監測、遠距醫療、穿戴式科技和居家復健計畫也促進了醫療服務向臨床環境之外的擴展，但可近性、依從性、保險報銷以及臨床療效的檢驗仍然是至關重要的考量。

人工智慧正在協助實現更個人化的關節疼痛治療。

人工智慧正被應用於診斷影像、症狀分類、臨床記錄、治療方案選擇、復健監測和病患參與等領域。這些工具能夠幫助識別X光片、磁振造影（MRI）、電子健康記錄和患者報告結局（PRO）中的通用模式，從而可能支持更早的干預和更一致的分診。安全實施人工智慧需要代表性的數據、透明的檢驗、臨床醫生的監督、隱私保護、網路安全以及明確的課責，以確保演算法建議不會對醫療照護產生影響。

區域趨勢：北美、拉丁美洲、歐洲、中東和非洲以及亞太地區的醫療服務取得差距

在北美，獲得專科護理、先進影像、復健和治療方案的機會普遍較多，但實際治療效果仍取決於成本效益、保險體系設計、鴉片類藥物相關政策以及遍遠地區的醫療資源取得。拉丁美洲的特點是公共和私營部門在提供醫療保健方面的能力存在差異，這為在基層醫療中擴大篩檢、康復和提供價格合理的藥物提供了機會。歐洲受益於完善的臨床指南和公共衛生基礎設施，但人口老化、醫療專業人員短缺以及報銷制度的差異影響著醫療服務的提供。在中東，對現代醫療保健系統的投資正在穩步推進，同時也在努力解決專科醫生分佈不均和確保持續護理的問題。在非洲，診斷、疼痛管理、復健和基本藥物方面存在顯著差異，因此任務分擔和社區模式至關重要。在亞太地區，雖然擁有先進的三級醫療保健系統，但仍有大規模人口無法獲得足夠的醫療服務。都市區差異、人口老化以及不同的法規環境正在影響傳統解決方案和數位解決方案的採用。

群體特定洞察：政策和經濟領域影響護理協調

由於醫療衛生系統能力存在差異，東協成員國在臨床培訓、藥品價格可負擔性、復健和數位醫療標準方面面臨嚴峻挑戰。金磚國家雖然擁有龐大的病患群體，但在資金籌措、基礎設施和專科醫生資源方面卻存在顯著差異，因此亟需擴充性且適應當地情況的醫療服務路徑。歐盟強調實證實踐、跨境醫療考量、資料管治以及慢性病的協調管理。七國集團（G7）的醫療衛生系統通常擁有強大的科學研究和臨床基礎設施，但必須應對人口老化、醫護人員短缺、成本效益和公平取得等挑戰。海灣合作理事會（GCC）成員國正在擴展其專科醫療機構，同時專注於預防、綜合醫療服務和國家層面的醫療衛生轉型。北約成員國的醫療衛生體系各不通用，但對於平民和軍人來說，增強醫療韌性、復原和持續照護都是至關重要的問題。

國家概況：澳洲、巴西、加拿大、中國、法國、德國、印度、義大利、日本、墨西哥、俄羅斯、韓國、西班牙、英國和

在澳大利亞，儘管臨床指南完善，但在確保農村和原住民地區獲得醫療服務方面仍面臨許多挑戰。巴西需要在其公共醫療體系內建立協調的路徑，提供可負擔的治療，並建立更廣泛的復健框架。加拿大仍在努力解決地域性醫療服務可近性、等待時間和省際差異等問題。中國在應對區域差異和人口快速老化的同時，也不斷提升其醫療和數位化能力。法國和德國已建立起專科和復健體系，並持續關注成本效益、人才引進和醫療協調。印度面臨顯著的都市區差距，但在可擴展的基層醫療、物理治療和低成本數位化模式方面蘊藏著巨大的機會。義大利、西班牙和英國正在努力平衡公共醫療需求、人口老化、候診名單和社區綜合護理等問題。在日本，隨著人口老化，預防、維持行動能力和長期功能支持的重要性日益凸顯。墨西哥需要更早的診斷、疼痛教育、復健服務，以及加強公立和私立醫療機構之間的合作。俄羅斯的醫療格局受到其地域遼闊、專科醫生分佈不均以及確保患者能夠持續獲得康復和藥物治療等因素的影響。在韓國，進步的驅動力來自先進技術的應用，以及人口老化和慢性肌肉骨骼疾病帶來的日益成長的需求。

產業優先事項：建構以證據為基礎、易於取得和一體化的照護路徑。

行業領導者應優先考慮那些能夠顯著改善疼痛、活動能力、生活品質和安全性的療法和服務。基層醫療、風濕病學、整形外科、物理治療、藥學和行為醫學等領域的協作可以緩解治療片段化的問題。數位化工具的設計應圍繞臨床工作流程和全面存取展開，並輔以嚴格的檢驗和人工監督。各機構也應致力於加強真實世界證據的收集，確保患者資訊的透明度，合理管理鴉片類藥物，實現公平定價和分配，培養人才，並採用不僅反映症狀，也反映患者功能狀態的療效評估方法。

調查方法：建構和整合臨床、政策和技術證據。

本執行摘要對慢性關節疼痛管理中已建立的模式進行了結構化、定性和綜合性的分析，涵蓋了治療方法、臨床環境、地區、國家醫療保健系統和技術應用領域。該方法考慮了臨床實踐的進步、醫療保健系統的能力、人口壓力、就醫障礙、監管和報銷環境以及負責任的人工智慧的應用。研究結果以方向性觀察而非定量市場預測的形式呈現，結論應結合目前的臨床指南、當地政策和獨立檢驗的證據進行解讀。

結論：更好的治療效果取決於協作和以患者為中心的管理。

慢性關節疼痛的治療正朝著個人化、多面向和功能導向護理的方向發展。最永續的進展將來自於預防、復健、適當的藥物和治療、負責任的數位創新以及加強醫療機構間的合作。我們需要靈活的醫療服務模式來應對地區和國家間的差異，並將人工智慧定位為臨床管理的輔助工具。那些專注於安全性、可近性、可衡量的結果和患者參與的領導者，將更有能力應對關節疼痛帶來的長期負擔。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：慢性關節疼痛治療方案市場：依治療類型分類

  • 替代療法
    • 針刺
    • 脊骨神經醫學
    • 草藥療法
  • 器械療法
    • 冷凍療法設備
    • 雷射治療設備
    • 經皮神經電刺激（TENS）裝置
    • 超音波治療設備
    • 穿戴式裝置
  • 數位療法
    • 行動應用
    • 遠端照護
    • 虛擬實境療法
  • 藥物治療
    • 皮質類固醇
    • 緩解疾病抗風濕藥物
      • 生物製劑
      • IL-6抑制劑
      • JAK抑制劑
      • TNF抑制劑
      • 羥氯喹
      • 胺基甲基葉酸
      • 柳氮磺胺吡啶
    • NSAIDs
      • COX-1抑制劑
      • COX-2抑制劑
    • 鴉片類藥物
  • 物理治療
    • 運動療法
    • 水處理方法
    • 手法治療

第8章：慢性關節疼痛治療方案市場：依給藥途徑分類

  • 注射藥物
  • 關節內
  • 口服
  • 外用
  • 經皮

第9章：關節慢性疼痛治療​​解決方案市場：按產品類型分類

  • 非處方藥
  • 處方

第10章：慢性關節疼痛治療市場：依疾病狀態分類

  • 痛風
  • 骨關節炎
  • 類風濕性關節炎

第11章：慢性關節疼痛治療方案市場：依作用機轉分類

  • 生物製劑
    • IL-6抑制劑
    • Jak抑制劑
    • TNF抑制劑
  • COX抑制劑
    • COX-1
    • COX-2
  • 玻尿酸注射
  • 調變器
    • 辣椒素
    • Lidocaine
  • 富血小板血漿（PRP）

第12章：慢性關節疼痛治療解決方案市場：依技術分類

  • 冷凍治療設備
  • 藥物輸送系統
  • 雷射治療設備
  • 經皮神經電刺激設備
  • 超音波治療設備
  • 穿戴式裝置

第13章：慢性關節疼痛治療解決方案市場：按最終用戶分類

  • 診所
  • 居家照護環境
  • 醫院

第14章：慢性關節疼痛治療方案市場：依通路分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房
  • 專科診所

第15章：慢性關節疼痛治療方案市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第16章：慢性關節疼痛治療方案市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章：慢性關節疼痛治療方案市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第19章：公司簡介

  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Biogen Inc.
  • Boston Scientific Corporation
  • Celgene Corporation
  • Co-Diagnostics, Inc.
  • Danaher Corporation
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Hologic, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic plc
  • Merck & Co., Inc.
  • Nevro Corp.
  • Novartis AG
  • Orthofix Medical Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Smith & Nephew plc
  • Stryker Corporation
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • UCB SA
  • Zimmer Biomet Holdings, Inc.
  • Zoetis Inc.

第20章 主要專家

Product Code: MRR-537DB9F46DB6

The Chronic Pain Therapy Solutions for Joints Market is projected to grow by USD 6.69 billion at a CAGR of 6.10% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.42 billion
Estimated Year [2026] USD 4.64 billion
Forecast Year [2032] USD 6.69 billion
CAGR (%) 6.10%

Chronic Joint Pain Therapy Solutions: Executive Overview

Chronic joint pain is a long-duration health challenge associated with osteoarthritis, inflammatory arthritis, prior injury, age-related degeneration, and other musculoskeletal conditions. Therapy solutions span nonpharmacological care, medicines, injections, physical rehabilitation, assistive technologies, and surgical intervention. Clinical decision-making increasingly emphasizes individualized treatment, functional improvement, safety, and coordinated long-term management rather than reliance on a single modality.

Care Is Shifting Toward Multimodal, Function-Focused Management

The treatment landscape is moving toward multimodal pathways that combine exercise therapy, weight management where clinically appropriate, education, behavioral support, medicines, and procedural care. Greater attention to opioid stewardship, adverse-event reduction, shared decision-making, and earlier rehabilitation is reshaping practice. Digital monitoring, remote consultations, wearable technologies, and home-based programs are also helping extend care beyond clinical settings, although access, adherence, reimbursement, and clinical validation remain important considerations.

Artificial Intelligence Is Supporting More Personalized Joint-Pain Care

Artificial intelligence is being applied to imaging interpretation, symptom classification, clinical documentation, treatment selection, rehabilitation monitoring, and patient engagement. These tools may help identify patterns across radiographs, magnetic resonance images, electronic records, and patient-reported outcomes, potentially supporting earlier intervention and more consistent triage. Safe deployment requires representative data, transparent validation, clinician oversight, privacy safeguards, cybersecurity, and clear accountability when algorithmic recommendations influence care.

Regional Insights: Uneven Access Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America generally has broad access to specialist care, advanced imaging, rehabilitation, and procedural options, while affordability, insurance design, opioid-related policy, and rural access continue to shape treatment. Latin America is characterized by varied public and private capacity, with opportunities to expand primary-care screening, rehabilitation, and affordable medicines. Europe benefits from established clinical guidelines and public health infrastructure, but aging populations, workforce constraints, and differences in reimbursement affect availability. The Middle East is investing in modern healthcare capacity while addressing variation in specialist distribution and continuity of care. Africa faces substantial gaps in diagnostics, pain services, rehabilitation, and essential medicines, making task-shared and community-based models important. Asia-Pacific combines advanced tertiary systems with large underserved populations; urban-rural disparities, demographic aging, and differing regulatory environments influence adoption of both conventional and digital solutions.

Group Insights: Policy and Economic Blocs Shape Care Coordination

ASEAN members face diverse health-system capacities, making regional cooperation on clinical training, affordable medicines, rehabilitation, and digital-health standards especially relevant. BRICS countries combine large patient populations with major differences in financing, infrastructure, and specialist access, creating a need for scalable and locally adaptable care pathways. The European Union emphasizes evidence-based practice, cross-border health considerations, data governance, and coordinated chronic-disease management. G7 systems generally possess strong research and clinical infrastructure but must address aging, workforce pressures, affordability, and equitable access. GCC countries are expanding specialized healthcare capacity while focusing on prevention, integrated delivery, and national health transformation. NATO members reflect varied healthcare structures, but shared attention to resilience, rehabilitation, and continuity of care is relevant for both civilian and service populations.

Country Insights: Diverse Priorities in Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, the UK, and

Australia combines strong clinical guidance with significant rural and Indigenous access challenges. Brazil requires coordinated public-system pathways, affordable treatment, and broader rehabilitation capacity. Canada continues to manage geographic access, wait times, and provincial variation. China is expanding healthcare and digital capabilities while addressing regional disparities and a rapidly aging population. France and Germany have established specialist and rehabilitation systems, with ongoing attention to cost-effectiveness, workforce capacity, and care coordination. India faces major urban-rural gaps and opportunities for scalable primary-care, physiotherapy, and low-cost digital models. Italy, Spain, and the United Kingdom are balancing public-system demand, aging, waiting lists, and integrated community care. Japan's aging population reinforces the importance of prevention, mobility preservation, and long-term functional support. Mexico needs stronger early diagnosis, pain education, rehabilitation access, and continuity between public and private providers. Russia's care environment is shaped by geographic scale, uneven specialist availability, and the need for consistent rehabilitation and medication access. South Korea combines advanced technology adoption with increasing demand linked to aging and chronic musculoskeletal conditions.

Industry Priorities: Build Evidence-Based, Accessible, and Integrated Care Pathways

Industry leaders should prioritize therapies and services that demonstrate meaningful improvements in pain, mobility, quality of life, and safety. Partnerships across primary care, rheumatology, orthopedics, physiotherapy, pharmacy, and behavioral health can reduce fragmented treatment. Digital tools should be designed around clinical workflows and inclusive access, with robust validation and human oversight. Organizations should also strengthen real-world evidence, transparent patient information, responsible opioid stewardship, equitable pricing and distribution, workforce training, and outcome measurement that reflects patient function rather than symptoms alone.

Methodology: Structured Synthesis of Clinical, Policy, and Technology Evidence

This executive summary uses a structured, qualitative synthesis of established patterns in chronic joint-pain management across therapies, care settings, regions, country systems, and technology applications. The approach considers clinical practice developments, health-system capacity, demographic pressures, access barriers, regulatory and reimbursement context, and responsible artificial-intelligence adoption. Insights are framed as directional observations rather than quantitative market claims, and conclusions should be interpreted alongside current clinical guidelines, local policies, and independently verified evidence.

Conclusion: Better Outcomes Depend on Coordinated, Patient-Centered Management

Chronic joint pain therapy is evolving toward personalized, multimodal, and function-oriented care. The most durable progress will come from combining prevention, rehabilitation, appropriate medicines and procedures, responsible digital innovation, and stronger continuity across healthcare settings. Regional and national differences require adaptable delivery models, while artificial intelligence should remain a clinically governed support tool. Leaders that focus on safety, access, measurable outcomes, and patient participation will be better positioned to address the long-term burden of joint pain.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Chronic Pain Therapy Solutions for Joints Market, by Therapy Type

  • 7.1. Introduction
  • 7.2. Alternative Therapy
    • 7.2.1. Acupuncture
    • 7.2.2. Chiropractic
    • 7.2.3. Herbal Remedies
  • 7.3. Device Therapy
    • 7.3.1. Cryotherapy Devices
    • 7.3.2. Laser Therapy Devices
    • 7.3.3. Transcutaneous Electrical Nerve Stimulation Devices
    • 7.3.4. Ultrasound Therapy Devices
    • 7.3.5. Wearable Devices
  • 7.4. Digital Therapy
    • 7.4.1. Mobile Applications
    • 7.4.2. Telemedicine
    • 7.4.3. Virtual Reality Therapy
  • 7.5. Drug Therapy
    • 7.5.1. Corticosteroids
    • 7.5.2. Disease Modifying Anti Rheumatic Drugs
      • 7.5.2.1. Biologics
      • 7.5.2.1.1. Il 6 Inhibitors
      • 7.5.2.1.2. Jak Inhibitors
      • 7.5.2.1.3. Tnf Inhibitors
      • 7.5.2.2. Hydroxychloroquine
      • 7.5.2.3. Methotrexate
      • 7.5.2.4. Sulfasalazine
    • 7.5.3. Nsaids
      • 7.5.3.1. Cox 1 Inhibitors
      • 7.5.3.2. Cox 2 Inhibitors
    • 7.5.4. Opioids
  • 7.6. Physical Therapy
    • 7.6.1. Exercise Therapy
    • 7.6.2. Hydrotherapy
    • 7.6.3. Manual Therapy

8. Chronic Pain Therapy Solutions for Joints Market, by Administration Route

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Intra Articular
  • 8.4. Oral
  • 8.5. Topical
  • 8.6. Transdermal

9. Chronic Pain Therapy Solutions for Joints Market, by Product Type

  • 9.1. Introduction
  • 9.2. Over The Counter
  • 9.3. Prescription

10. Chronic Pain Therapy Solutions for Joints Market, by Pathology

  • 10.1. Introduction
  • 10.2. Gout
  • 10.3. Osteoarthritis
  • 10.4. Rheumatoid Arthritis

11. Chronic Pain Therapy Solutions for Joints Market, by Mechanism Of Action

  • 11.1. Introduction
  • 11.2. Biologics
    • 11.2.1. Il 6 Inhibitors
    • 11.2.2. Jak Inhibitors
    • 11.2.3. Tnf Inhibitors
  • 11.3. Cox Inhibitors
    • 11.3.1. Cox 1
    • 11.3.2. Cox 2
  • 11.4. Hyaluronic Acid Injections
  • 11.5. Neuromodulators
    • 11.5.1. Capsaicin
    • 11.5.2. Lidocaine
  • 11.6. Platelet Rich Plasma

12. Chronic Pain Therapy Solutions for Joints Market, by Technology

  • 12.1. Introduction
  • 12.2. Cryotherapy Devices
  • 12.3. Drug Delivery Systems
  • 12.4. Laser Therapy Devices
  • 12.5. Tens Devices
  • 12.6. Ultrasound Therapy Devices
  • 12.7. Wearable Devices

13. Chronic Pain Therapy Solutions for Joints Market, by End User

  • 13.1. Introduction
  • 13.2. Clinics
  • 13.3. Homecare Settings
  • 13.4. Hospitals

14. Chronic Pain Therapy Solutions for Joints Market, by Distribution Channel

  • 14.1. Introduction
  • 14.2. Hospital Pharmacies
  • 14.3. Online Pharmacies
  • 14.4. Retail Pharmacies
  • 14.5. Specialty Clinics

15. Chronic Pain Therapy Solutions for Joints Market, by Region

  • 15.1. Introduction
  • 15.2. Asia-Pacific
  • 15.3. North America
  • 15.4. Latin America
  • 15.5. Europe
  • 15.6. Middle East
  • 15.7. Africa

16. Chronic Pain Therapy Solutions for Joints Market, by Group

  • 16.1. Introduction
  • 16.2. ASEAN
  • 16.3. GCC
  • 16.4. European Union
  • 16.5. BRICS
  • 16.6. G7
  • 16.7. NATO

17. Chronic Pain Therapy Solutions for Joints Market, by Country

  • 17.1. Introduction
  • 17.2. United States
  • 17.3. Canada
  • 17.4. Mexico
  • 17.5. Brazil
  • 17.6. United Kingdom
  • 17.7. Germany
  • 17.8. France
  • 17.9. Russia
  • 17.10. Italy
  • 17.11. Spain
  • 17.12. China
  • 17.13. India
  • 17.14. Japan
  • 17.15. Australia
  • 17.16. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2025
  • 18.2. Market Concentration Analysis, 2025
    • 18.2.1. Concentration Ratio (CR)
    • 18.2.2. Herfindahl Hirschman Index (HHI)
  • 18.3. Recent Developments & Impact Analysis, 2025
  • 18.4. Product Portfolio Analysis, 2025
  • 18.5. Benchmarking Analysis, 2025

19. Company Profiles

  • 19.1. Abbott Laboratories
  • 19.2. AbbVie Inc.
  • 19.3. Amgen Inc.
  • 19.4. B. Braun Melsungen AG
  • 19.5. Baxter International Inc.
  • 19.6. Biogen Inc.
  • 19.7. Boston Scientific Corporation
  • 19.8. Celgene Corporation
  • 19.9. Co-Diagnostics, Inc.
  • 19.10. Danaher Corporation
  • 19.11. Eli Lilly and Company
  • 19.12. Gilead Sciences, Inc.
  • 19.13. GlaxoSmithKline plc
  • 19.14. Hologic, Inc.
  • 19.15. Integra LifeSciences Holdings Corporation
  • 19.16. Johnson & Johnson Services, Inc.
  • 19.17. Medtronic plc
  • 19.18. Merck & Co., Inc.
  • 19.19. Nevro Corp.
  • 19.20. Novartis AG
  • 19.21. Orthofix Medical Inc.
  • 19.22. Pfizer Inc.
  • 19.23. Sanofi S.A.
  • 19.24. Smith & Nephew plc
  • 19.25. Stryker Corporation
  • 19.26. Sun Pharmaceutical Industries Ltd.
  • 19.27. Teva Pharmaceutical Industries Ltd.
  • 19.28. UCB S.A.
  • 19.29. Zimmer Biomet Holdings, Inc.
  • 19.30. Zoetis Inc.

20. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Chronic Pain Therapy Solutions for Joints Market, Years Considered for the Study
  • FIGURE 2. Global Chronic Pain Therapy Solutions for Joints Market, Research Design
  • FIGURE 3. Global Chronic Pain Therapy Solutions for Joints Market, Research Framework
  • FIGURE 4. Global Chronic Pain Therapy Solutions for Joints Market, Data Triangulation
  • FIGURE 5. Global Chronic Pain Therapy Solutions for Joints Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2025 vs 2032 (%)
  • FIGURE 9. Global Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 11. Global Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2025 vs 2032 (%)
  • FIGURE 13. Global Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2025 vs 2032 (%)
  • FIGURE 15. Global Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2025 vs 2032 (%)
  • FIGURE 17. Global Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 19. Global Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 21. Global Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 22. Global Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 23. Global Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 24. Global Chronic Pain Therapy Solutions for Joints Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 25. Global Chronic Pain Therapy Solutions for Joints Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 26. Global Chronic Pain Therapy Solutions for Joints Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 27. Global Chronic Pain Therapy Solutions for Joints Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Chronic Pain Therapy Solutions for Joints Market Segmentation & Coverage
  • TABLE 2. Global Chronic Pain Therapy Solutions for Joints Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
  • TABLE 4. Global Alternative Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Alternative Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Alternative Therapy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Acupuncture Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Acupuncture Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Acupuncture Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Chiropractic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Chiropractic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Chiropractic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Herbal Remedies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Herbal Remedies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Herbal Remedies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Device Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Device Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Device Therapy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Cryotherapy Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Cryotherapy Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Cryotherapy Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Laser Therapy Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Laser Therapy Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Laser Therapy Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Transcutaneous Electrical Nerve Stimulation Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Transcutaneous Electrical Nerve Stimulation Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Transcutaneous Electrical Nerve Stimulation Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Ultrasound Therapy Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Ultrasound Therapy Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Ultrasound Therapy Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Wearable Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Wearable Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Wearable Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Digital Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Digital Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Digital Therapy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Mobile Applications Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Mobile Applications Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Mobile Applications Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Telemedicine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Telemedicine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Telemedicine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Virtual Reality Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Virtual Reality Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Virtual Reality Therapy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Drug Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Drug Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Drug Therapy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Corticosteroids Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Corticosteroids Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Corticosteroids Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Disease Modifying Anti Rheumatic Drugs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Disease Modifying Anti Rheumatic Drugs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Disease Modifying Anti Rheumatic Drugs Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global Biologics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global Biologics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global Biologics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Il 6 Inhibitors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Il 6 Inhibitors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Il 6 Inhibitors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global Jak Inhibitors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Global Jak Inhibitors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 63. Global Jak Inhibitors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 64. Global Tnf Inhibitors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 65. Global Tnf Inhibitors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 66. Global Tnf Inhibitors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 67. Global Hydroxychloroquine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 68. Global Hydroxychloroquine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 69. Global Hydroxychloroquine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 70. Global Methotrexate Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 71. Global Methotrexate Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 72. Global Methotrexate Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 73. Global Sulfasalazine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 74. Global Sulfasalazine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 75. Global Sulfasalazine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 76. Global Nsaids Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 77. Global Nsaids Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 78. Global Nsaids Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 79. Global Cox 1 Inhibitors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 80. Global Cox 1 Inhibitors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 81. Global Cox 1 Inhibitors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 82. Global Cox 2 Inhibitors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 83. Global Cox 2 Inhibitors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 84. Global Cox 2 Inhibitors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 85. Global Opioids Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 86. Global Opioids Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 87. Global Opioids Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 88. Global Physical Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 89. Global Physical Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 90. Global Physical Therapy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 91. Global Exercise Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 92. Global Exercise Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 93. Global Exercise Therapy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 94. Global Hydrotherapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 95. Global Hydrotherapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 96. Global Hydrotherapy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 97. Global Manual Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 98. Global Manual Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 99. Global Manual Therapy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 100. Global Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 101. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 102. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 103. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 104. Global Intra Articular Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 105. Global Intra Articular Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 106. Global Intra Articular Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 107. Global Oral Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 108. Global Oral Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 109. Global Oral Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 110. Global Topical Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 111. Global Topical Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 112. Global Topical Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 113. Global Transdermal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 114. Global Transdermal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 115. Global Transdermal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 116. Global Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 117. Global Over The Counter Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 118. Global Over The Counter Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 119. Global Over The Counter Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 120. Global Prescription Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 121. Global Prescription Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 122. Global Prescription Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 123. Global Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2017-2032 (USD Million)
  • TABLE 124. Global Gout Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 125. Global Gout Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 126. Global Gout Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 127. Global Osteoarthritis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 128. Global Osteoarthritis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 129. Global Osteoarthritis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 130. Global Rheumatoid Arthritis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 131. Global Rheumatoid Arthritis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 132. Global Rheumatoid Arthritis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 133. Global Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2017-2032 (USD Million)
  • TABLE 134. Global Biologics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 135. Global Biologics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 136. Global Biologics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 137. Global Il 6 Inhibitors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 138. Global Il 6 Inhibitors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 139. Global Il 6 Inhibitors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 140. Global Jak Inhibitors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 141. Global Jak Inhibitors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 142. Global Jak Inhibitors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 143. Global Tnf Inhibitors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 144. Global Tnf Inhibitors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 145. Global Tnf Inhibitors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 146. Global Cox Inhibitors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 147. Global Cox Inhibitors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 148. Global Cox Inhibitors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 149. Global Cox 1 Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 150. Global Cox 1 Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 151. Global Cox 1 Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 152. Global Cox 2 Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 153. Global Cox 2 Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 154. Global Cox 2 Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 155. Global Hyaluronic Acid Injections Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 156. Global Hyaluronic Acid Injections Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 157. Global Hyaluronic Acid Injections Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 158. Global Neuromodulators Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 159. Global Neuromodulators Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 160. Global Neuromodulators Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 161. Global Capsaicin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 162. Global Capsaicin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 163. Global Capsaicin Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 164. Global Lidocaine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 165. Global Lidocaine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 166. Global Lidocaine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 167. Global Platelet Rich Plasma Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 168. Global Platelet Rich Plasma Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 169. Global Platelet Rich Plasma Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 170. Global Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 171. Global Cryotherapy Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 172. Global Cryotherapy Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 173. Global Cryotherapy Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 174. Global Drug Delivery Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 175. Global Drug Delivery Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 176. Global Drug Delivery Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 177. Global Laser Therapy Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 178. Global Laser Therapy Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 179. Global Laser Therapy Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 180. Global Tens Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 181. Global Tens Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 182. Global Tens Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 183. Global Ultrasound Therapy Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 184. Global Ultrasound Therapy Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 185. Global Ultrasound Therapy Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 186. Global Wearable Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 187. Global Wearable Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 188. Global Wearable Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 189. Global Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 190. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 191. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 192. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 193. Global Homecare Settings Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 194. Global Homecare Settings Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 195. Global Homecare Settings Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 196. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 197. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 198. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 199. Global Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 200. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 201. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 202. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 203. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 204. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 205. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 206. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 207. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 208. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 209. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 210. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 211. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 212. Global Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 213. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 214. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
  • TABLE 215. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Alternative Therapy, 2017-2032 (USD Million)
  • TABLE 216. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Device Therapy, 2017-2032 (USD Million)
  • TABLE 217. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Digital Therapy, 2017-2032 (USD Million)
  • TABLE 218. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Drug Therapy, 2017-2032 (USD Million)
  • TABLE 219. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Disease Modifying Anti Rheumatic Drugs, 2017-2032 (USD Million)
  • TABLE 220. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 221. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Nsaids, 2017-2032 (USD Million)
  • TABLE 222. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Physical Therapy, 2017-2032 (USD Million)
  • TABLE 223. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 224. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 225. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2017-2032 (USD Million)
  • TABLE 226. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2017-2032 (USD Million)
  • TABLE 227. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 228. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Cox Inhibitors, 2017-2032 (USD Million)
  • TABLE 229. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Neuromodulators, 2017-2032 (USD Million)
  • TABLE 230. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 231. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 232. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 233. North America Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 234. North America Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
  • TABLE 235. North America Chronic Pain Therapy Solutions for Joints Market Size, by Alternative Therapy, 2017-2032 (USD Million)
  • TABLE 236. North America Chronic Pain Therapy Solutions for Joints Market Size, by Device Therapy, 2017-2032 (USD Million)
  • TABLE 237. North America Chronic Pain Therapy Solutions for Joints Market Size, by Digital Therapy, 2017-2032 (USD Million)
  • TABLE 238. North America Chronic Pain Therapy Solutions for Joints Market Size, by Drug Therapy, 2017-2032 (USD Million)
  • TABLE 239. North America Chronic Pain Therapy Solutions for Joints Market Size, by Disease Modifying Anti Rheumatic Drugs, 2017-2032 (USD Million)
  • TABLE 240. North America Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 241. North America Chronic Pain Therapy Solutions for Joints Market Size, by Nsaids, 2017-2032 (USD Million)
  • TABLE 242. North America Chronic Pain Therapy Solutions for Joints Market Size, by Physical Therapy, 2017-2032 (USD Million)
  • TABLE 243. North America Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 244. North America Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 245. North America Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2017-2032 (USD Million)
  • TABLE 246. North America Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2017-2032 (USD Million)
  • TABLE 247. North America Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 248. North America Chronic Pain Therapy Solutions for Joints Market Size, by Cox Inhibitors, 2017-2032 (USD Million)
  • TABLE 249. North America Chronic Pain Therapy Solutions for Joints Market Size, by Neuromodulators, 2017-2032 (USD Million)
  • TABLE 250. North America Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 251. North America Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 252. North America Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 253. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 254. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
  • TABLE 255. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Alternative Therapy, 2017-2032 (USD Million)
  • TABLE 256. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Device Therapy, 2017-2032 (USD Million)
  • TABLE 257. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Digital Therapy, 2017-2032 (USD Million)
  • TABLE 258. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Drug Therapy, 2017-2032 (USD Million)
  • TABLE 259. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Disease Modifying Anti Rheumatic Drugs, 2017-2032 (USD Million)
  • TABLE 260. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 261. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Nsaids, 2017-2032 (USD Million)
  • TABLE 262. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Physical Therapy, 2017-2032 (USD Million)
  • TABLE 263. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 264. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 265. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2017-2032 (USD Million)
  • TABLE 266. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2017-2032 (USD Million)
  • TABLE 267. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 268. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Cox Inhibitors, 2017-2032 (USD Million)
  • TABLE 269. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Neuromodulators, 2017-2032 (USD Million)
  • TABLE 270. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 271. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 272. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 273. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 274. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
  • TABLE 275. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Alternative Therapy, 2017-2032 (USD Million)
  • TABLE 276. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Device Therapy, 2017-2032 (USD Million)
  • TABLE 277. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Digital Therapy, 2017-2032 (USD Million)
  • TABLE 278. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Drug Therapy, 2017-2032 (USD Million)
  • TABLE 279. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Disease Modifying Anti Rheumatic Drugs, 2017-2032 (USD Million)
  • TABLE 280. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 281. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Nsaids, 2017-2032 (USD Million)
  • TABLE 282. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Physical Therapy, 2017-2032 (USD Million)
  • TABLE 283. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 284. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 285. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2017-2032 (USD Million)
  • TABLE 286. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2017-2032 (USD Million)
  • TABLE 287. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 288. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Cox Inhibitors, 2017-2032 (USD Million)
  • TABLE 289. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Neuromodulators, 2017-2032 (USD Million)
  • TABLE 290. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 291. Europe Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 292. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 293. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 294. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
  • TABLE 295. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Alternative Therapy, 2017-2032 (USD Million)
  • TABLE 296. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Device Therapy, 2017-2032 (USD Million)
  • TABLE 297. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Digital Therapy, 2017-2032 (USD Million)
  • TABLE 298. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Drug Therapy, 2017-2032 (USD Million)
  • TABLE 299. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Disease Modifying Anti Rheumatic Drugs, 2017-2032 (USD Million)
  • TABLE 300. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 301. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Nsaids, 2017-2032 (USD Million)
  • TABLE 302. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Physical Therapy, 2017-2032 (USD Million)
  • TABLE 303. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 304. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 305. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2017-2032 (USD Million)
  • TABLE 306. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2017-2032 (USD Million)
  • TABLE 307. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 308. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Cox Inhibitors, 2017-2032 (USD Million)
  • TABLE 309. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Neuromodulators, 2017-2032 (USD Million)
  • TABLE 310. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 311. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 312. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 313. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 314. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
  • TABLE 315. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Alternative Therapy, 2017-2032 (USD Million)
  • TABLE 316. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Device Therapy, 2017-2032 (USD Million)
  • TABLE 317. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Digital Therapy, 2017-2032 (USD Million)
  • TABLE 318. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Drug Therapy, 2017-2032 (USD Million)
  • TABLE 319. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Disease Modifying Anti Rheumatic Drugs, 2017-2032 (USD Million)
  • TABLE 320. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 321. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Nsaids, 2017-2032 (USD Million)
  • TABLE 322. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Physical Therapy, 2017-2032 (USD Million)
  • TABLE 323. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2017-2032 (USD Million)
  • TABLE 324. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 325. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2017-2032 (USD Million)
  • TABLE 326. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2017-2032 (USD Million)
  • TABLE 327. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 328. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Cox Inhibitors, 2017-2032 (USD Million)
  • TABLE 329. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Neuromodulators, 2017-2032 (USD Million)
  • TABLE 330. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 331. Africa Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 332. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 333. Global Chronic Pain Therapy Solutions for Joints Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 334. ASEAN Chronic Pain Therapy Solutions for Joints Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 335. ASEAN Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
  • TABLE 336. ASEAN Chronic Pain Therapy Solutions for Joints Market Size, by Alternative Therapy, 2017-2032 (USD Million)
  • TABLE 337. ASEAN Chronic Pain Therapy Solutions for Joints Market Size, by Device Therapy, 2017-2032 (USD Million)
  • TABLE 338. ASEAN Chronic Pain Therapy Solutions for Joints Market Size, by Digital Therapy, 2017-2032 (USD Million)

TAB